SG Americas Securities
HBIO icon

SG Americas Securities’s Harvard Bioscience HBIO Stock Holding History

SG Americas Securities’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,150
Closed -$10K – 3457
2025
Q2 		$10K Buy
2,150
+975
+83% +$4.07K ﹤0.01% 2856
2025
Q1 		$7K Sell
1,175
-541
-32% -$6.93K ﹤0.01% 3419
2024
Q4 		$36K Buy
1,716
+375
+28% +$8.61K ﹤0.01% 2960
2024
Q3 		$36K Buy
+1,341
New +$39.5K ﹤0.01% 3299
2021
Q4 		– Sell
-1,482
Closed -$103K – 3559
2021
Q3 		$103K Buy
+1,482
New +$118K ﹤0.01% 3655
2020
Q3 		– Sell
-2,089
Closed -$65K – 3002
2020
Q2 		$65K Buy
+2,089
New +$56.3K ﹤0.01% 3487
2019
Q3 		– Sell
-1,195
Closed -$24K – 3087
2019
Q2 		$24K Buy
+1,195
New +$35K ﹤0.01% 2982

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SG Americas Securities's HBIO Position: Q3 2025 in Review

SG Americas Securities sold out of Harvard Bioscience (HBIO) in Q3 2025, closing a stake of 2,150 shares — an estimated $10K sold.

SG Americas Securities first reported a position in HBIO in Q2 2019 and held it in 7 quarters. The position peaked at $103K in Q3 2021. 59 funds tracked by Wall St. Rank hold HBIO as of Q3 2025.

  • SG Americas Securities reported no remaining Harvard Bioscience position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 2,150 Harvard Bioscience shares in Q3 2025, an estimated $10K.
  • SG Americas Securities first reported a position in Harvard Bioscience in Q2 2019 and held it in 7 quarters.
  • SG Americas Securities's Harvard Bioscience position peaked at $103K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.